Plain-English translation of NCT07777536 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether a more focused radiation therapy approach works just as well as traditional radiation therapy for aggressive thyroid cancers (poorly differentiated and anaplastic types). Researchers believe the targeted approach may control cancer as effectively while reducing harm to healthy tissue and improving your quality of life.
Aggressive thyroid cancers are serious and difficult to treat. Standard radiation therapy covers a large area to ensure all cancer cells are treated, but this can damage healthy organs and tissue nearby. This trial is exploring whether treating only the specific cancer area could work as well while reducing side effects and keeping patients healthier.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either selective (targeted) radiation therapy or comprehensive (whole-area) radiation therapy. Both approaches involve multiple treatment sessions over several weeks at a radiation center. You'll have imaging scans before, during, and after treatment, and you'll complete quality-of-life questionnaires to help researchers track how you're doing. Your medical team will monitor you closely for side effects and cancer control, with a focus on your health 12 months after starting treatment.
AI-generated summary from trial data · Aug 26, 2026 · Not medical advice
China